When should ART be started in an HIV-positive child?

AIIMS CRE 2025

Child Health Nursing (Pediatrics)

Easy

Appeared in: AIIMS CRE 2025

Explanation

Current global guidelines (WHO, NIH) recommend a 'Treat All' strategy for pediatric HIV.
ART should be started immediately upon diagnosis for all children, regardless of their clinical symptoms, CD4 count, or viral load.
Early treatment is crucial as infants and young children have a very high risk of rapid disease progression and mortality if left untreated.
Studies like the CHER trial have definitively shown that immediate ART in infants significantly reduces mortality and preserves immune function.

Option A: Waiting for symptoms allows the virus to cause significant and often irreversible damage to the immune system.
Option C: This is extremely dangerous. The highest risk of death from pediatric HIV is in the first two years of life. Delaying treatment would lead to preventable deaths.
Option D: This is an obsolete criterion from an era when ART had more toxicity. Waiting for the CD4 count to drop this low signifies severe immunodeficiency (AIDS) and places the child at high risk for life-threatening opportunistic infections.

Visual 1: Flowchart: 'Pediatric HIV 'Treat All' Pathway'. This would show the steps from a positive HIV test in a child directly to the initiation of ART, bypassing any conditional checks for symptoms or CD4 counts.
Visual 2: Infographic: 'Early vs. Delayed ART in Children'. This could visually compare the outcomes, showing lower mortality, better growth, and preserved immune function in the early ART group versus the high risk of opportunistic infections and death in the delayed group.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Timing of Antiretroviral Therapy (ART) initiation in pediatric HIV infection as background academic context rather than a clinical decision trigger.
A nurse's primary role is to advocate for immediate treatment initiation and provide comprehensive education to caregivers about why it is non-negotiable for the child's survival and long-term health.
Nurses are central to managing adherence, which is critical for the success of ART. This involves simplifying regimens, using reminders, and building a trusting relationship with the family.
What if the child is diagnosed with HIV and also has active tuberculosis (TB)? In this case, ART is still urgently needed. However, the timing might be carefully managed in consultation with an HIV specialist to avoid Immune Reconstitution Inflammatory Syndrome (IRIS). TB treatment would be started first, followed by ART within a few weeks, not indefinitely delayed.

How to Approach the Question

Identify the core question: It asks for the correct timing to start a specific treatment (ART) for a specific population (HIV-positive children).
Recognize this as a clinical practice guideline question. These guidelines are frequently updated based on new evidence.
Recall or deduce the most current standard of care. For HIV, the paradigm has shifted from 'wait and monitor' to 'Treat All' or 'Test and Treat'.
Evaluate the options based on this modern principle. Options suggesting any form of delay (waiting for symptoms, age, or low CD4 count) are likely to be outdated and incorrect.
Select the option that aligns with immediate intervention, as this maximizes benefits and minimizes the risk of disease progression in a vulnerable population.

Concept Tested & Keywords

Concept Tested: Timing of Antiretroviral Therapy (ART) initiation in pediatric HIV infection.
Stem keywords: ART, HIV-positive child, started
Lead-in keywords: When
Clinical cues: Age/sex group narrows the expected diagnosis, intervention, or normal reference range.
Negative lead-in flag: false

QD9HpI2WwwmQeEdFP-4BPm